Immunovant (IMVT) Superinvestor holders
13 of the superinvestors we track hold Immunovant (IMVT) in their latest 13F filings, $464M in total.
Summary
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $224M, 1.3% of the portfolio.
In their latest quarter: 7 opened a new position, 3 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | 5,805,000 | $224M | 1.3% | Q2 2026 |
| Jennison Associates | Added | 3,310,238 | $128M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 1,240,654 | $48M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 726,800 | $28M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
New position | 545,730 | $18M | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 142,488 | $5M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
New position | 140,116 | $5M | 0.0% | Q2 2026 |
| David Einhorn Greenlight Capital |
Held | 93,520 | $4M | 0.1% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 57,145 | $2M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | 30,100 | $1M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
New position | 11,082 | $426,990 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 5,206 | $200,587 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 1,902 | $64,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 11 |
| Q1 2026 | 6 |
| Q4 2025 | 5 |
| Q3 2025 | 8 |
| Q2 2025 | 5 |
| Q1 2025 | 8 |
| Q4 2024 | 6 |
| Q3 2024 | 11 |
Questions about Immunovant
Which superinvestors own Immunovant?
13 of the superinvestors we track hold Immunovant (IMVT) in their latest 13F filings, $464M in total. Tom Steyer, Jennison Associates, David Shaw, Jim Simons, Ken Fisher, Paul Marshall.
Who is the largest superinvestor holder of IMVT?
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $224M, 1.3% of the portfolio.
From Immunovant's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.